Part Details | FAMOTIDINE INJECTION
6505-01-646-7199
Alternate Parts: NDC63323073820, NDC63323-0738-20, 1349403, 6505NCM152334, NDC63323073820, NDC63323-0738-20, 6505-01-646-7199, 01-646-7199, 6505016467199, 016467199
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | JUL 29, 2015 | 01-646-7199 | 39058 ( FAMOTIDINE INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-646-7199
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC63323-0738-20 | 7BM13 | AMERISOURCEBERGEN CORPORATION |
| 1349403 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM152334 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NDC63323-0738-20 | 57KZ6 | FRESENIUS KABI USA, LLC |
Technical Data | NSN 6505-01-646-7199
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB200.0 MILLIGRAMS FAMOTIDINE |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER TYPE | VIAL, MULTIPLE DOSE |
| PRIMARY CONTAINER CONTENT QUANTITY | 20.0 MILLILITERS |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| SPECIAL FEATURES | FAMOTIDINE INJ; 10MG/ML MULTIPLE DOSE VIAL; 20ML VIALS X 10 VIALS PER TRAY; FAMOTIDINE IS A COMPETITIVE INHIBITOR OF HISTAMINE H2 RECEPTORS; THE PRIMARY CLINICALLY IMPORTANT PHARMACOLOGIC ACTIVITY OF FAMOTIDINE IS INHIBITION OF GASTRIC SECRETION; STORE CONTAINER AT 2-8 DEGREES C; FOR INTRAVENOUS USE ONLY AFTER DILUTION; DILUTED FAMOTIDINE INJECTION SHOULD BE REFRIGERATED AND USED WITHIN 48 HOURS |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | PEPCID |